Free Trial

InterCure (INCR) Stock Price, News & Analysis

InterCure logo
$1.74
+0.03 (+1.75%)
(As of 11/1/2024 ET)

About InterCure Stock (NASDAQ:INCR)

Key Stats

Today's Range
$1.73
$1.76
50-Day Range
$1.70
$2.27
52-Week Range
$0.99
$3.72
Volume
15,256 shs
Average Volume
53,380 shs
Market Capitalization
$79.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

InterCure Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
25th Percentile Overall Score

INCR MarketRank™: 

InterCure scored higher than 25% of companies evaluated by MarketBeat, and ranked 870th out of 976 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Book Value per Share Ratio

    InterCure has a P/B Ratio of 0.64. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.07% of the float of InterCure has been sold short.
  • Short Interest Ratio / Days to Cover

    InterCure has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InterCure has recently decreased by 12.75%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    InterCure does not currently pay a dividend.

  • Dividend Growth

    InterCure does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.07% of the float of InterCure has been sold short.
  • Short Interest Ratio / Days to Cover

    InterCure has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InterCure has recently decreased by 12.75%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    InterCure has a news sentiment score of 1.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for InterCure this week, compared to 0 articles on an average week.
  • Search Interest

    Only 2 people have searched for INCR on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, InterCure insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.24% of the stock of InterCure is held by insiders.

  • Percentage Held by Institutions

    Only 8.34% of the stock of InterCure is held by institutions.

  • Read more about InterCure's insider trading history.
Receive INCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InterCure and its competitors with MarketBeat's FREE daily newsletter.

INCR Stock News Headlines

InterCure Ltd. (INCR)
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
See More Headlines

INCR Stock Analysis - Frequently Asked Questions

InterCure's stock was trading at $1.2898 at the beginning of 2024. Since then, INCR shares have increased by 34.9% and is now trading at $1.74.
View the best growth stocks for 2024 here
.

Shares of INCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that InterCure investors own include NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), Advanced Micro Devices (AMD), Tesla (TSLA), Innovative Industrial Properties (IIPR) and AbbVie (ABBV).

Company Calendar

Today
11/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:INCR
Fax
N/A
Employees
350
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$96.61 million
Book Value
$2.72 per share

Miscellaneous

Free Float
45,464,000
Market Cap
$79.29 million
Optionable
Optionable
Beta
1.50
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (NASDAQ:INCR) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners